Morphine Sulfate

Front 1

Classification

Back 1

Opiod Narcotic, CNS Depressant

Front 2

Mechanism of action

Back 2

1. alters pain perception and produces euphoria
2. Decreases myocradial oxygen demand by decreasing preload ( enous pooling due to peripheral vasodilation) and decreasing after load (decreased systemic vascular resistance due to peripheral vasodilation)
3. Depresses the cps by interacting with opiate receptors in the brain

Front 3

Indications

Back 3

1. Moderate to severe pain
2. Chest pain of suspected myocardial origin
3. pulmonary Edema from CHF with or without chest pain
4. Burns

Front 4

Contraindications

Back 4

1. Altered level of consciousness
2. Adominal pain of unknown etiology
3. Patients at risk of respiratory depression
4. Head injury
5. Hypovolemia

Front 5

Side Effects

Back 5

CARDIOVASCULAR: Bradycardia, hypotension, (rebound tachycardia/hypretension)
NEUROLOGICAL: sedation, agitation, trmors/seizures, hallucinations
RESPIRATORY: Depression, arrest
GASTROINTESTINAL: nausea/vomiting

Front 6

Precautions

Back 6

Morphine sulfate is an opiate derivative- Naloxone should be available to reverse any severe respiratory side effects

Front 7

Interactions

Back 7

Use with caution with patients taking other analgesic, depressants or narcotics

Front 8

Routes of Administration

Back 8

IV, IO, IM

Front 9

Onset and duration of actions

Back 9

IV/IO will have an onset of 2-5 minutes and IM will have an onset of 5-10 minutes. EAch will last approximately 3-5 hours

Front 10

Dosages

Back 10

ADULT:
Pain Relief: 1.0-10.0 mg IV titrated to pain relief or 5.0-10.0 mg IM as a single dose only
Pulmonary Edema 5.0 - 10.0 mg slow IV push (2.0 mg/minute)
PEDIATRIC: .1-.2 mg/kg slow IV push (1.0 mg/minute) titrated to pain relief or 0.1 mg/kg IM

Front 11

Notes

Back 11

MAy draw 10 mg (1 ml) into a 10 ml syringe and mix with 9 ml normal saline. This creates i mg.1 ml concentration for better control when administering the medication